FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves a supplemental application for clobetasol propionate from E. Fougera & Co. (division of Fougera Pharmaceuticals Inc.), under the ANDA, authorizing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Contact Dermatitis
• Dermatitis
• Psoriasis
• Seborrheic Dermatitis

Drugs mentioned

• CLOBETASOL PROPIONATE (Clobetasol propionate)

Snippet

SUPPL AP for CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE)